We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BOLD market cap is 2.92B. The company's latest EPS is USD -0.1585 and P/E is -59.43.
Quarter End | |
---|---|
USD (US$) | |
Total Revenue | |
Operating Income | |
Net Income |
Year End December 30 2023 | 2023 |
---|---|
USD (US$) | |
Total Revenue | 0 |
Operating Income | -54.8M |
Net Income | -49.43M |
Quarter End | |
---|---|
USD (US$) | |
Total Assets | |
Total Liabilities | |
Total Equity |
Year End December 30 2023 | 2023 |
---|---|
USD (US$) | |
Total Assets | 129.89M |
Total Liabilities | 9.36M |
Total Equity | -127.08M |
Market Cap | 2.92B |
Price to Earnings Ratio | -59.43 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 123.95 |
Price to Book Ratio | 24.37 |
Dividend Yield | - |
Shares Outstanding | 311.79M |
Average Volume (1 week) | 110.34k |
Average Volume (1 Month) | 149.66k |
52 Week Change | -34.39% |
52 Week High | 15.20 |
52 Week Low | 8.53 |
Spread (Intraday) | 9.03 (50.59%) |
Company Name | Boundless Bio Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.boundlessbio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions